Yvonne Brandberg
Overview
Explore the profile of Yvonne Brandberg including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
109
Citations
1751
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hunde D, Ekerstad N, Asp M, Kannisto P, Wedin M, Palmqvist C, et al.
Acta Oncol
. 2025 Feb;
64:208-213.
PMID: 39907536
Background And Purpose: There is an urgent need to improve patient-selection to surgical treatment in advanced ovarian cancer as our results showed that cytoreductive surgery was without effect or even...
2.
Brandberg Y, Akre O, Bergenmar M
Acta Oncol
. 2025 Jan;
64:167-172.
PMID: 39876690
Background And Purpose: Informed consent from trial participants is mandatory. In a randomized clinical trial, we investigated (1) differences in knowledge and understanding of trial information between patients who participated...
3.
Matikas A, Mobus V, Greil R, Andersson A, Steger G, Untch M, et al.
J Clin Oncol
. 2024 Jul;
42(26):3077-3082.
PMID: 39018515
JCO .Although dose-dense adjuvant chemotherapy administered once every 2 weeks leads to superior outcomes compared with standard regimens once every 3 weeks, the observed improvement is largely limited to studies...
4.
Johansson H, Lagergren P, Nolte S, Brandberg Y
Acta Oncol
. 2023 Oct;
62(12):1592-1598.
PMID: 37862371
Background: Normative health-related quality of life (HRQoL) data from the general population are regularly used to facilitate the interpretation of HRQoL as reported by cancer patients participating in cancer clinical...
5.
Musoro J, Coens C, Sprangers M, Brandberg Y, Groenvold M, Flechtner H, et al.
Eur J Cancer
. 2023 May;
188:171-182.
PMID: 37257278
Introduction: Early guidelines for minimally important differences (MIDs) for the EORTC QLQ-C30 proposed ≥10 points change as clinically meaningful for all scales. Increasing evidence that MIDs can vary by scale,...
6.
Omran M, Johansson H, Lundgren C, Silander G, Stenmark-Askmalm M, Loman N, et al.
Cancer
. 2023 Jan;
129(6):946-955.
PMID: 36601958
Background: To evaluate the psychosocial consequences of surveillance with whole-body MRI (WB-MRI) in individuals with the heritable TP53-related cancer (hTP53rc) syndrome, also known as the Li-Fraumeni syndrome, with regard to...
7.
Hjalm-Eriksson M, Ullen A, Nilsson S, Johansson H, Nilsson J, Castellanos E, et al.
Acta Oncol
. 2022 Sep;
61(10):1179-1185.
PMID: 36062835
Background And Purpose: The aim of this cross-sectional study was to investigate long-term health-related quality of life (HRQoL) in men with prostate cancer treated 2002-2008 with external beam radiotherapy (EBRT)...
8.
Machingura A, Taye M, Musoro J, Ringash J, Pe M, Coens C, et al.
Eur J Cancer
. 2022 May;
170:1-9.
PMID: 35569438
Introduction: The European Organisation for Research and Treatment of Cancer Quality of Life Core Questionnaire (EORTC QLQ-C30) measures 15 health-related quality of life (HRQoL) scales relevant to the disease and...
9.
Naeser Y, Helgadottir H, Hansson J, Ingvar C, Elander N, Flygare P, et al.
Cancers (Basel)
. 2022 Feb;
14(4).
PMID: 35205786
The benefit of imaging in the follow-up setting for high-risk melanoma patients is uncertain, and even less is known about the impact of intensive follow-up on the patient´s quality of...
10.
Omran M, Tham E, Brandberg Y, Ahlstrom H, Lundgren C, Paulsson-Karlsson Y, et al.
Cancers (Basel)
. 2022 Jan;
14(2).
PMID: 35053544
A surveillance strategy of the heritable -related cancer syndrome (hrc), commonly referred to as the Li-Fraumeni syndrome (LFS), is studied in a prospective observational nationwide multi-centre study in Sweden (SWEP53)....